Lundbeck Acquires Longboard Pharmaceuticals; Paul Sekhri Joins iOnctura Board
1 report, 1 independent
Updated Oct 15
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lundbeck acquired Longboard Pharmaceuticals. Separately, Paul Sekhri strengthened iOnctura’s board. Sekhri, who previously served as Chair of Longboard Pharmaceuticals, joined the board as iOnctura prepares for late-stage development of roginolisib.
From manilatimes.net
Why it matters
The acquisition of Longboard Pharmaceuticals by Lundbeck is a significant corporate transaction. Paul Sekhri's appointment to iOnctura's board brings extensive experience in strategic transactions and financing as the company advances its pipeline.
From manilatimes.net
Who's involved
- LundbeckCompleted the acquisition of Longboard Pharmaceuticals